Thursday, June 15, 2023 2:58:42 PM
IIOT-OXYS, Inc. Onboards New Advisor to Accelerate Biotech - Pharma Industry 4.0 Business Vertical
CAMBRIDGE, MA / ACCESSWIRE / June 15, 2023 / IIOT-OXYS, Inc. (OTC PINK:ITOX) ("Oxys" or the "Company") announced the appointment of William D'Agostino to its Advisory Board as a Technical Sales Consultant for his expertise in Biotechnology and Pharmaceutical Continuous Manufacturing Processes. A full bio for Mr. D'Agostino will be posted on the Company's website.
Cliff Emmons, CEO of Oxys, stated, "We are excited to have Bill join our team to help us drive sales & marketing efforts that will expand the growth of this critical business segment for Oxys, specifically with Biotech & Pharma prospects. He has already identified several qualified leads in these verticals, and we expect our efforts to result in the announcement of a Proof of Concept with a new customer from these verticals by the end of third quarter 2023."
The worldwide Industry 4.0 (also known as Smart Manufacturing) market was estimated at $97.6 B USD in 2022 and is expected to grow at 18.5% CAGR to $228.3 billion by 2027.1 Bringing on Mr. D'Agostino is one of several actions the Company has taken recently to accelerate growth in this critical sector.
"We're confident we'll continue to build on our Smart Manufacturing success with Bill's Continuous Manufacturing expertise. Combined with our proprietary AI and Machine Learning algorithms, strong business partnerships, successful pilots and use cases, along with our extensive network and prospects, we expect these marketing efforts will lead to new business in due time," concluded Mr. Emmons.
About IIOT-OXYS, Inc.
IIOT-OXYS, Inc. (OTC PINK: ITOX) is a technology company at the intersection of IIoT, AI & Machine Learning, Edge Computing and Manufacturing Operations. We provide actionable mission-critical insights for the Medical/Pharmaceutical, Manufacturing, Agriculture, Defense, and Structural Health, and other industries. IIOT-OXYS's edge computing open-source hardware and proprietary ML algorithms employ our Minimally Invasive Load Monitoring (MILM) technology to simply gather data and gain insights to monitor, scope, move from preventive to predictive maintenance, and even optimize development and manufacturing processes. For additional information visit www.oxyscorp.com.
Forward-Looking Statements
This news release contains forward-looking statements that reflect Management's current views about future events and financial performance. Forward-looking statements often contain words such as ''expects,'' ''anticipates,'' ''intends,'' or ''believes.'' Our forward-looking statements are subject to a number of risks and uncertainties that may cause actual results and events to differ materially from those projected in the forward-looking statements. Risks and uncertainties that could adversely affect us include, without limitation, the loss of major customers, our failure to obtain new contracts, our inability to patent products or processes, our infringement of patents held by others, our inability to finance our business and the other risks and uncertainties that are discussed in our most recent filings with the Securities and Exchange Commission. The forward-looking statements in this news release are made only as of the date of this news release. We undertake no obligation to update our forward-looking statements, whether as a result of new information, future events or otherwise.
Contact Information:
IIOT-OXYS, Inc.
Clifford L. Emmons
CEO
contact@oxyscorp.com
www.oxyscorp.com
Recent ITOX News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 03:24:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 09:01:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 08:26:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:30:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2023 09:29:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/25/2023 12:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 03:56:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 09:25:36 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 04:17:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 08:01:12 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM